Cytek Biosciences, Inc.

CTKB

CTKBCytek Biosciences, Inc. US flag

NASDAQ Global Select

4.54

USD

-0.03

- -

586.31MMarket Cap

Profitability (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	13.37	0.88	0.52	-2.4	-1.21	-13.85
Return on Capital (%)	- -	- -	-19.83	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	2.35	- -	- -	- -	- -
Gross Margin (%)	49.54	55.7	61.86	61.56	56.69	55.43	51.84
EBITDA Margin (%)	5.31	15.36	8.13	2.35	-9.64	-5.01	-14.1
Operating Margin (%)	4.77	14.71	7.16	-1.1	-14.43	-10.24	-20.04
Incremental Operating Margin (%)	- -	31.17	-12.82	- -	- -	- -	- -
Pretax Margin (%)	-28.15	15.54	4.64	0.77	-8.14	-2.84	-14.81
Profit Margin (%)	-29.07	20.91	2.35	1.57	-6.29	-3	-33.02
Net Income to Common Margin (%)	-29.07	20.91	2.35	1.57	-6.29	-3	-33.02
Effective Tax Rate (%)	- -	- -	49.02	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	3	- -	18	14	17	24
ST Debt	- -	3	- -	4	3	8	9
LT Debt	- -	- -	- -	15	11	9	15
Total Debt/EBITDA	- -	0.19	- -	4.69	-0.76	-1.7	-0.84
Net Debt/EBITDA	-9.81	-11.39	-35.06	-76.2	8.87	9.27	2.96
Total Debt/EBIT	- -	0.2	- -	-10.03	-0.51	-0.83	-0.59
Net Debt/EBIT	-10.9	-11.89	-39.82	162.83	5.93	4.53	2.08
EBITDA to Interest Expense	3,072	42.83	5.97	1.5	-8.99	- -	-59.93
EBITDA-CapEx/Interest Expense	2,099	38.18	3.47	-2.34	-11.32	- -	-68.77
EBIT to Interest Expense	2,763	41.02	5.26	-0.7	-13.45	- -	-85.2
Interest Expense	- -	- -	2	3	2	- -	- -
Common Equity/Total Assets	-59.69	-10.27	-4.2	-3.25	-5.87	-7.02	-22.02
Long-Term Debt/Equity (%)	- -	- -	- -	3.43	2.83	2.17	4.26
Long-Term Debt/Capital (%)	- -	- -	- -	1,005.72	-74.62	-47.65	-18.71
Long-Term Debt/Total Assets (%)	- -	- -	- -	2.81	2.25	1.72	3.16
Total Debt/Equity (%)	- -	-17.29	- -	4.25	3.6	4.3	6.95
Total Debt/Capital (%)	- -	-13.99	- -	1,247.86	-94.8	-94.25	-30.49
Total Debt/Total Assets (%)	- -	1.26	- -	3.48	2.86	3.41	5.14
Net Debt to Equity	72.23	1,013.59	-89.94	-69.03	-42	-23.5	-24.59
Net Debt/Capital (%)	41.77	87.8	95.01	99.53	90.6	79.65	49.81
EBITDA	3	14	10	4	-19	-10	-28
EBITDA-CapEx	2	13	6	-6	-23	-14	-33
Operating Income (Loss)	3	14	9	-2	-28	-21	-40

Liquidity (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.43	6.23	10.99	6.96	4.67	4.11	3.36
Current Ratio	3.22	7.86	13.01	9.26	6.97	5.86	5.04
Quick Ratio	2.28	6.91	11.88	7.99	5.67	5	4.29
CFO/Avg Current Liab	- -	0.64	0.16	-0.3	0.1	0.41	-0.06
Common Equity/Total Assets	-59.69	-10.27	-4.2	-3.25	-5.87	-7.02	-22.02
Long-Term Debt/Equity (%)	- -	- -	- -	3.43	2.83	2.17	4.26
Long-Term Debt/Capital (%)	- -	- -	- -	1,005.72	-74.62	-47.65	-18.71
Long-Term Debt/Total Assets (%)	- -	- -	- -	2.81	2.25	1.72	3.16
Total Debt/Equity (%)	- -	-17.29	- -	4.25	3.6	4.3	6.95
Total Debt/Capital (%)	- -	-13.99	- -	1,247.86	-94.8	-94.25	-30.49
Total Debt/Total Assets (%)	- -	1.26	- -	3.48	2.86	3.41	5.14
CFO/Total Liabilities	-12.27	6.42	7.99	-13.02	5.21	24.46	-3.91
CFO/CapEx	-14.13	9.8	1.06	-1.24	1.09	6.81	-1.12
Altman's Z-Score	0.92	1.48	14.33	10	8.07	5.93	3.94

Working Capital (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	5.44	5.47	4.17	3.68	3.44	3.27
Days Sales Outstanding	- -	67.11	66.68	87.47	99.08	106.08	111.49
Inventory Turnover	- -	1.98	1.77	1.57	1.53	1.71	2.1
Days Inventory Outstanding	- -	183.93	206.37	232.46	238.05	214	173.64
Accounts Payable Turnover	- -	17.3	19.39	20.17	24.58	16.91	17.01
Accounts Payable Turnover Days	- -	21.1	18.82	18.1	14.85	21.59	21.45
Cash Conversion Cycle	- -	229.94	254.23	301.83	322.28	298.49	263.68
Inventory to Cash Days	- -	-116.82	-139.69	-144.98	-138.96	-107.92	-62.14
Inventories	18	23	32	48	61	44	48
Raw Materials	12	13	17	27	36	23	20
Work In Process	2	3	2	5	10	6	17
Finished Goods	5	7	13	16	15	15	11
Other Inventory	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	1,252	1,373	1,192	848	645
- Cash & Cash Equivalents	30	165	365	297	167	99	91
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	3	- -	18	14	17	24
Enterprise Value	-30	-162	888	1,051	944	587	407
Total Capital	-42	-20	-19	1	-15	-18	-78
Total Debt/Capital (%)	- -	-13.99	- -	1,247.86	-94.8	-94.25	-30.49
Total Debt / EV	- -	-0.02	- -	0.02	0.01	0.03	0.06
EV/Sales	- -	- -	6.94	6.4	4.89	2.93	2.02
EV/EBITDA	- -	- -	85.41	272.52	- -	- -	- -
EV/EBIT	- -	- -	96.99	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	160.97	- -	137.14	23.12	- -
EV/Free Cash Flow to Firm	- -	- -	89.88	387.73	80.6	20.16	726.19
Diluted Market Cap	- -	- -	1,331	1,415	1,192	848	645
Diluted Enterprise Value	-30	-162	967	1,136	1,039	766	578
EV per Share	- -	- -	11.57	7.81	7.22	4.49	3.19
TTM Sales	58	93	128	164	193	200	201
TTM EBITDA	3	14	10	4	-19	-10	-28
TTM Operating Income	3	14	9	-2	-28	-21	-40
TTM Cash Flow to Firm	-14	16	6	-7	7	25	-4
TTM Free Cash Flow to Firm	-13	17	10	3	12	29	1

Multiples (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	147.97	-598.7	117.94	29.12	-1,300.64
EV/EBIT	- -	- -	96.99	- -	- -	- -	- -
Enterprise Value	-30	-162	888	1,051	944	587	407
Low Price	- -	- -	15.91	7.38	3.8	4.66	2.37
EV/Sales	- -	- -	6.94	6.4	4.89	2.93	2.02
EV/EBITDA	- -	- -	85.41	272.52	- -	- -	- -
Price/Earnings	- -	- -	417.34	533.13	- -	- -	- -
Price/Earnings Average	- -	- -	564.12	651.64	-91.45	-138.19	-8.1
Price/Earnings High	- -	- -	733.92	909.1	-148.17	-202.43	-14.02
Price/Earnings Low	- -	- -	406.85	385.36	-40.89	-101.1	-4.55
Price/Book Value	- -	- -	-64.29	-81.29	-41.04	-24.17	-6.35
Price/Book Value Average	- -	- -	-86.91	-99.36	-38.25	-23.72	-5.31
Price/Book Value High	- -	- -	-113.06	-138.61	-61.97	-34.75	-9.18
Price/Book Value Low	- -	- -	-62.68	-58.76	-17.1	-17.36	-2.98
Price/Tangible Book Value	- -	- -	3.21	3.34	3.37	2.36	2.09
Price/Tangible Book Value Average	- -	- -	4.34	4.08	3.14	2.32	1.75
Price/Tangible Book Value High	- -	- -	5.64	5.7	5.09	3.39	3.03
Price/Tangible Book Value Low	- -	- -	3.13	2.41	1.4	1.7	0.98
Price/Sales	- -	- -	9.79	8.37	6.18	4.23	3.2
Price/Sales Average	- -	- -	13.23	10.23	5.76	4.15	2.68
Price/Sales High	- -	- -	17.21	14.28	9.33	6.08	4.63
Price/Sales Low	- -	- -	9.54	6.05	2.57	3.04	1.5
Price/Cash Flow	- -	- -	270.5	-112.28	225.74	33.4	-137.67
Price/Cash Flow Average	- -	- -	365.65	-137.24	210.38	32.78	-115.04
Price/Cash Flow High	- -	- -	475.7	-191.47	340.83	48.02	-199.01
Price/Cash Flow Low	- -	- -	263.71	-81.16	94.06	23.98	-64.61
Price/Free Cash Flow Average	- -	- -	200.01	-731.77	109.91	28.58	-1,086.86
Price/Free Cash Flow High	- -	- -	260.22	-1,020.89	178.07	41.86	-1,880.13
Price/Free Cash Flow Low	- -	- -	144.25	-432.75	49.14	20.91	-610.4
EV/Sales Average	- -	- -	10.38	8.54	4.96	3.74	2.34
EV/Sales High	- -	- -	14.37	12.58	8.53	5.67	4.3
EV/Sales Low	- -	- -	6.7	4.36	1.78	2.63	1.17
EV/EBITDA Average	-9.81	-11.39	127.77	363.26	-51.45	-74.77	-16.61
EV/EBITDA High	-9.81	-11.39	176.77	535.3	-88.47	-113.32	-30.46
EV/EBITDA Low	-9.81	-11.39	82.38	185.33	-18.46	-52.52	-8.29
EV/EBIT Average	-10.9	-11.89	145.1	-776.25	-34.4	-36.55	-11.69
EV/EBIT High	-10.9	-11.89	200.74	-1,143.89	-59.14	-55.4	-21.43
EV/EBIT Low	-10.9	-11.89	93.56	-396.03	-12.34	-25.68	-5.84
Last Price	- -	- -	16.32	10.21	9.12	6.49	5.05
High Price	- -	- -	28.7	17.41	13.77	9.33	7.3
Enterprise Value Average	-30	-162	1,329	1,400	958	750	472
Enterprise Value High	-30	-162	1,838	2,064	1,647	1,137	865
Enterprise Value Low	-30	-162	857	714	344	527	236

Profitability (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	13.37	0.88	0.52	-2.4	-1.21	-13.85
Return on Capital (%)	- -	- -	-19.83	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	2.35	- -	- -	- -	- -
Gross Margin (%)	49.54	55.7	61.86	61.56	56.69	55.43	51.84
EBITDA Margin (%)	5.31	15.36	8.13	2.35	-9.64	-5.01	-14.1
Operating Margin (%)	4.77	14.71	7.16	-1.1	-14.43	-10.24	-20.04
Incremental Operating Margin (%)	- -	31.17	-12.82	- -	- -	- -	- -
Pretax Margin (%)	-28.15	15.54	4.64	0.77	-8.14	-2.84	-14.81
Profit Margin (%)	-29.07	20.91	2.35	1.57	-6.29	-3	-33.02
Net Income to Common Margin (%)	-29.07	20.91	2.35	1.57	-6.29	-3	-33.02
Effective Tax Rate (%)	- -	- -	49.02	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	3	- -	18	14	17	24
ST Debt	- -	3	- -	4	3	8	9
LT Debt	- -	- -	- -	15	11	9	15
Total Debt/EBITDA	- -	0.19	- -	4.69	-0.76	-1.7	-0.84
Net Debt/EBITDA	-9.81	-11.39	-35.06	-76.2	8.87	9.27	2.96
Total Debt/EBIT	- -	0.2	- -	-10.03	-0.51	-0.83	-0.59
Net Debt/EBIT	-10.9	-11.89	-39.82	162.83	5.93	4.53	2.08
EBITDA to Interest Expense	3,072	42.83	5.97	1.5	-8.99	- -	-59.93
EBITDA-CapEx/Interest Expense	2,099	38.18	3.47	-2.34	-11.32	- -	-68.77
EBIT to Interest Expense	2,763	41.02	5.26	-0.7	-13.45	- -	-85.2
Interest Expense	- -	- -	2	3	2	- -	- -
Common Equity/Total Assets	-59.69	-10.27	-4.2	-3.25	-5.87	-7.02	-22.02
Long-Term Debt/Equity (%)	- -	- -	- -	3.43	2.83	2.17	4.26
Long-Term Debt/Capital (%)	- -	- -	- -	1,005.72	-74.62	-47.65	-18.71
Long-Term Debt/Total Assets (%)	- -	- -	- -	2.81	2.25	1.72	3.16
Total Debt/Equity (%)	- -	-17.29	- -	4.25	3.6	4.3	6.95
Total Debt/Capital (%)	- -	-13.99	- -	1,247.86	-94.8	-94.25	-30.49
Total Debt/Total Assets (%)	- -	1.26	- -	3.48	2.86	3.41	5.14
Net Debt to Equity	72.23	1,013.59	-89.94	-69.03	-42	-23.5	-24.59
Net Debt/Capital (%)	41.77	87.8	95.01	99.53	90.6	79.65	49.81
EBITDA	3	14	10	4	-19	-10	-28
EBITDA-CapEx	2	13	6	-6	-23	-14	-33
Operating Income (Loss)	3	14	9	-2	-28	-21	-40

Liquidity (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.43	6.23	10.99	6.96	4.67	4.11	3.36
Current Ratio	3.22	7.86	13.01	9.26	6.97	5.86	5.04
Quick Ratio	2.28	6.91	11.88	7.99	5.67	5	4.29
CFO/Avg Current Liab	- -	0.64	0.16	-0.3	0.1	0.41	-0.06
Common Equity/Total Assets	-59.69	-10.27	-4.2	-3.25	-5.87	-7.02	-22.02
Long-Term Debt/Equity (%)	- -	- -	- -	3.43	2.83	2.17	4.26
Long-Term Debt/Capital (%)	- -	- -	- -	1,005.72	-74.62	-47.65	-18.71
Long-Term Debt/Total Assets (%)	- -	- -	- -	2.81	2.25	1.72	3.16
Total Debt/Equity (%)	- -	-17.29	- -	4.25	3.6	4.3	6.95
Total Debt/Capital (%)	- -	-13.99	- -	1,247.86	-94.8	-94.25	-30.49
Total Debt/Total Assets (%)	- -	1.26	- -	3.48	2.86	3.41	5.14
CFO/Total Liabilities	-12.27	6.42	7.99	-13.02	5.21	24.46	-3.91
CFO/CapEx	-14.13	9.8	1.06	-1.24	1.09	6.81	-1.12
Altman's Z-Score	0.92	1.48	14.33	10	8.07	5.93	3.94

Working Capital (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	5.44	5.47	4.17	3.68	3.44	3.27
Days Sales Outstanding	- -	67.11	66.68	87.47	99.08	106.08	111.49
Inventory Turnover	- -	1.98	1.77	1.57	1.53	1.71	2.1
Days Inventory Outstanding	- -	183.93	206.37	232.46	238.05	214	173.64
Accounts Payable Turnover	- -	17.3	19.39	20.17	24.58	16.91	17.01
Accounts Payable Turnover Days	- -	21.1	18.82	18.1	14.85	21.59	21.45
Cash Conversion Cycle	- -	229.94	254.23	301.83	322.28	298.49	263.68
Inventory to Cash Days	- -	-116.82	-139.69	-144.98	-138.96	-107.92	-62.14
Inventories	18	23	32	48	61	44	48
Raw Materials	12	13	17	27	36	23	20
Work In Process	2	3	2	5	10	6	17
Finished Goods	5	7	13	16	15	15	11
Other Inventory	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	1,252	1,373	1,192	848	645
- Cash & Cash Equivalents	30	165	365	297	167	99	91
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	3	- -	18	14	17	24
Enterprise Value	-30	-162	888	1,051	944	587	407
Total Capital	-42	-20	-19	1	-15	-18	-78
Total Debt/Capital (%)	- -	-13.99	- -	1,247.86	-94.8	-94.25	-30.49
Total Debt / EV	- -	-0.02	- -	0.02	0.01	0.03	0.06
EV/Sales	- -	- -	6.94	6.4	4.89	2.93	2.02
EV/EBITDA	- -	- -	85.41	272.52	- -	- -	- -
EV/EBIT	- -	- -	96.99	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	160.97	- -	137.14	23.12	- -
EV/Free Cash Flow to Firm	- -	- -	89.88	387.73	80.6	20.16	726.19
Diluted Market Cap	- -	- -	1,331	1,415	1,192	848	645
Diluted Enterprise Value	-30	-162	967	1,136	1,039	766	578
EV per Share	- -	- -	11.57	7.81	7.22	4.49	3.19
TTM Sales	58	93	128	164	193	200	201
TTM EBITDA	3	14	10	4	-19	-10	-28
TTM Operating Income	3	14	9	-2	-28	-21	-40
TTM Cash Flow to Firm	-14	16	6	-7	7	25	-4
TTM Free Cash Flow to Firm	-13	17	10	3	12	29	1

Multiples (USD)

API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	147.97	-598.7	117.94	29.12	-1,300.64
EV/EBIT	- -	- -	96.99	- -	- -	- -	- -
Enterprise Value	-30	-162	888	1,051	944	587	407
Low Price	- -	- -	15.91	7.38	3.8	4.66	2.37
EV/Sales	- -	- -	6.94	6.4	4.89	2.93	2.02
EV/EBITDA	- -	- -	85.41	272.52	- -	- -	- -
Price/Earnings	- -	- -	417.34	533.13	- -	- -	- -
Price/Earnings Average	- -	- -	564.12	651.64	-91.45	-138.19	-8.1
Price/Earnings High	- -	- -	733.92	909.1	-148.17	-202.43	-14.02
Price/Earnings Low	- -	- -	406.85	385.36	-40.89	-101.1	-4.55
Price/Book Value	- -	- -	-64.29	-81.29	-41.04	-24.17	-6.35
Price/Book Value Average	- -	- -	-86.91	-99.36	-38.25	-23.72	-5.31
Price/Book Value High	- -	- -	-113.06	-138.61	-61.97	-34.75	-9.18
Price/Book Value Low	- -	- -	-62.68	-58.76	-17.1	-17.36	-2.98
Price/Tangible Book Value	- -	- -	3.21	3.34	3.37	2.36	2.09
Price/Tangible Book Value Average	- -	- -	4.34	4.08	3.14	2.32	1.75
Price/Tangible Book Value High	- -	- -	5.64	5.7	5.09	3.39	3.03
Price/Tangible Book Value Low	- -	- -	3.13	2.41	1.4	1.7	0.98
Price/Sales	- -	- -	9.79	8.37	6.18	4.23	3.2
Price/Sales Average	- -	- -	13.23	10.23	5.76	4.15	2.68
Price/Sales High	- -	- -	17.21	14.28	9.33	6.08	4.63
Price/Sales Low	- -	- -	9.54	6.05	2.57	3.04	1.5
Price/Cash Flow	- -	- -	270.5	-112.28	225.74	33.4	-137.67
Price/Cash Flow Average	- -	- -	365.65	-137.24	210.38	32.78	-115.04
Price/Cash Flow High	- -	- -	475.7	-191.47	340.83	48.02	-199.01
Price/Cash Flow Low	- -	- -	263.71	-81.16	94.06	23.98	-64.61
Price/Free Cash Flow Average	- -	- -	200.01	-731.77	109.91	28.58	-1,086.86
Price/Free Cash Flow High	- -	- -	260.22	-1,020.89	178.07	41.86	-1,880.13
Price/Free Cash Flow Low	- -	- -	144.25	-432.75	49.14	20.91	-610.4
EV/Sales Average	- -	- -	10.38	8.54	4.96	3.74	2.34
EV/Sales High	- -	- -	14.37	12.58	8.53	5.67	4.3
EV/Sales Low	- -	- -	6.7	4.36	1.78	2.63	1.17
EV/EBITDA Average	-9.81	-11.39	127.77	363.26	-51.45	-74.77	-16.61
EV/EBITDA High	-9.81	-11.39	176.77	535.3	-88.47	-113.32	-30.46
EV/EBITDA Low	-9.81	-11.39	82.38	185.33	-18.46	-52.52	-8.29
EV/EBIT Average	-10.9	-11.89	145.1	-776.25	-34.4	-36.55	-11.69
EV/EBIT High	-10.9	-11.89	200.74	-1,143.89	-59.14	-55.4	-21.43
EV/EBIT Low	-10.9	-11.89	93.56	-396.03	-12.34	-25.68	-5.84
Last Price	- -	- -	16.32	10.21	9.12	6.49	5.05
High Price	- -	- -	28.7	17.41	13.77	9.33	7.3
Enterprise Value Average	-30	-162	1,329	1,400	958	750	472
Enterprise Value High	-30	-162	1,838	2,064	1,647	1,137	865
Enterprise Value Low	-30	-162	857	714	344	527	236

Shares Outstanding	131	131	134	135	131	129	129
Diluted Weighted Avg Shares	105	36	82	139	131	131	128
Basic Weighted Avg Shares	102	32	77	135	131	131	128
Revenue per Share	0.57	2.94	1.67	1.22	1.48	1.53	1.58
EBITDA per Share	0.03	0.45	0.14	0.03	-0.14	-0.08	-0.22
Operating Income per Share	0.03	0.43	0.12	-0.01	-0.21	-0.16	-0.32
Basic EPS, GAAP	-0.16	0.62	0.04	0.02	-0.09	-0.05	-0.52
Basic EPS from Cont Ops	-0.16	0.62	0.04	0.02	-0.09	-0.05	-0.52
Diluted EPS, GAAP	-0.16	0.54	0.04	0.02	-0.09	-0.05	-0.52
Diluted EPS from Cont Ops	-0.16	0.54	0.04	0.02	-0.09	-0.05	-0.52
Dividend per Share	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.13	0.48	0.06	-0.09	0.04	0.19	-0.04
Free Cash Flow per Basic Share	-0.14	0.43	- -	-0.16	- -	0.17	-0.07
Cash & Equivalents per Share	0.3	5.24	4.75	2.54	2.01	2.13	2.05
Book Value per Share	-0.41	-0.72	-0.25	-0.13	-0.22	-0.27	-0.8
Tangible Book Value per Share	-0.42	-0.53	5.09	3.06	2.71	2.75	2.41

Cytek Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)